Cite
HARVARD Citation
Turco, N. et al. (2018). A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections. Expert opinion on pharmacotherapy. pp. 319-325. [Online].